---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-073769"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:29:55.149451+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lineage Cell Therapeutics dismisses Withum, appoints Moss Adams as auditor

## Summary
- Audit committee dismissed WithumSmith+Brown effective June 11, 2024.
- Engaged Moss Adams as independent auditor for fiscal year ending Dec 31, 2024.
- No disagreements or reportable events with former auditor in past two years.

## SEC filing metadata
- accession: 0000950170-24-073769
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/0000950170-24-073769-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/lctx-20240614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-073769
- JSON: https://secwatch.observer/filing/0000950170-24-073769.json
- Plain text: https://secwatch.observer/filing/0000950170-24-073769.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.